drugset / Trial / NCT01261741
Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
RandomizedParallel-groupDouble-blindTreatment
Summary
In this study, memantine will be tested in a new indication: in the treatment of subjective memory, concentration, or attention problems (subjective cognitive impairment) in the absence of dementia.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-08
- Completion
- 2011-09
Publications
- Results Schulz JB, Acker C, Seitzinger A, Pulte I. Randomized, double-blind, placebo-controlled, multicentre study to investigate memantine in the treatment of memory, concentration, and attention problems (subjective cognitive impairment). Journal of the Neurological Sciences 333 Suppl.1: e332, 2013. doi:10.1016/j.jns.2013.07.1232
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 10 mg | — |